What are the currently available dosing formulations of CD/LD, and what potential advance in PD treatment has been made possible with the availability of a CD/LD fractionable dosing formulation (Dhivy®)?

What are the currently available dosing formulations of CD/LD, and what potential advance in PD treatment has been made possible with the availability of a CD/LD fractionable dosing formulation (Dhivy®)?

What are the currently available dosing formulations of CD/LD, and what potential advance in PD treatment has been made possible with the availability of a CD/LD fractionable dosing formulation (Dhivy®)?


Created by

CMEducation Resources iQ&A Parkinson’s Disease (PD) Medical Intelligence Zone

Related Presenters

Laxman Bahroo, DO, FAAN

Laxman Bahroo, DO, FAAN

Associate Professor, Department of Neurology Georgetown University Medical Center Vice Chair of Finance Director, Residency Program Director, Botulinum Toxin Clinic Associate Professor of Neurology Medstar Georgetown University HospitalWashington, D.C.